Annual FCF
-$109.11 M
-$3.55 M-3.36%
31 December 2023
Summary:
Celldex Therapeutics annual free cash flow is currently -$109.11 million, with the most recent change of -$3.55 million (-3.36%) on 31 December 2023. During the last 3 years, it has fallen by -$67.15 million (-160.06%). CLDX annual FCF is now -742.76% below its all-time high of $16.98 million, reached on 31 December 2008.CLDX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$55.88 M
-$26.28 M-88.78%
01 September 2024
Summary:
Celldex Therapeutics quarterly free cash flow is currently -$55.88 million, with the most recent change of -$26.28 million (-88.78%) on 01 September 2024. Over the past year, it has dropped by -$36.73 million (-191.81%). CLDX quarterly FCF is now -253.51% below its all-time high of $36.40 million, reached on 31 March 2006.CLDX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$159.66 M
-$36.73 M-29.88%
01 September 2024
Summary:
Celldex Therapeutics TTM free cash flow is currently -$159.66 million, with the most recent change of -$36.73 million (-29.88%) on 01 September 2024. Over the past year, it has dropped by -$61.76 million (-63.08%). CLDX TTM FCF is now -558.93% below its all-time high of $34.79 million, reached on 31 March 2006.CLDX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.4% | -191.8% | -63.1% |
| 3 y3 years | -160.1% | -237.5% | -202.7% |
| 5 y5 years | -43.5% | -395.3% | -209.2% |
CLDX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -160.1% | at low | -275.6% | at low | -202.7% | at low |
| 5 y | 5 years | -160.1% | at low | -923.9% | at low | -280.6% | at low |
| alltime | all time | -742.8% | +5.8% | -253.5% | at low | -558.9% | at low |
Celldex Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$55.88 M(+88.8%) | -$159.66 M(+29.9%) |
| June 2024 | - | -$29.60 M(-27.8%) | -$122.93 M(+1.6%) |
| Mar 2024 | - | -$40.98 M(+23.4%) | -$120.94 M(+10.8%) |
| Dec 2023 | -$109.11 M(+3.4%) | -$33.20 M(+73.4%) | -$109.11 M(+11.4%) |
| Sept 2023 | - | -$19.15 M(-30.6%) | -$97.91 M(-14.3%) |
| June 2023 | - | -$27.61 M(-5.3%) | -$114.29 M(+4.3%) |
| Mar 2023 | - | -$29.15 M(+32.5%) | -$109.61 M(+3.8%) |
| Dec 2022 | -$105.56 M(+69.8%) | -$22.00 M(-38.1%) | -$105.56 M(+7.2%) |
| Sept 2022 | - | -$35.54 M(+55.1%) | -$98.44 M(+23.9%) |
| June 2022 | - | -$22.92 M(-8.7%) | -$79.46 M(+15.8%) |
| Mar 2022 | - | -$25.11 M(+68.8%) | -$68.62 M(+10.4%) |
| Dec 2021 | -$62.16 M(+48.2%) | -$14.88 M(-10.1%) | -$62.16 M(+17.9%) |
| Sept 2021 | - | -$16.56 M(+37.1%) | -$52.74 M(+9.4%) |
| June 2021 | - | -$12.07 M(-35.3%) | -$48.20 M(-0.1%) |
| Mar 2021 | - | -$18.65 M(+241.7%) | -$48.26 M(+15.0%) |
| Dec 2020 | -$41.96 M(-11.0%) | -$5.46 M(-54.6%) | -$41.96 M(-11.9%) |
| Sept 2020 | - | -$12.02 M(-0.9%) | -$47.60 M(+1.6%) |
| June 2020 | - | -$12.13 M(-1.7%) | -$46.86 M(+1.7%) |
| Mar 2020 | - | -$12.35 M(+11.2%) | -$46.07 M(-2.3%) |
| Dec 2019 | -$47.15 M(-38.0%) | -$11.11 M(-1.6%) | -$47.15 M(-8.7%) |
| Sept 2019 | - | -$11.28 M(-0.5%) | -$51.63 M(-5.8%) |
| June 2019 | - | -$11.34 M(-15.5%) | -$54.80 M(-10.4%) |
| Mar 2019 | - | -$13.42 M(-13.9%) | -$61.19 M(-19.5%) |
| Dec 2018 | -$76.05 M(-25.2%) | -$15.59 M(+7.9%) | -$76.05 M(-5.1%) |
| Sept 2018 | - | -$14.45 M(-18.5%) | -$80.17 M(-11.3%) |
| June 2018 | - | -$17.73 M(-37.3%) | -$90.36 M(-4.2%) |
| Mar 2018 | - | -$28.28 M(+43.5%) | -$94.36 M(-7.2%) |
| Dec 2017 | -$101.72 M(-12.1%) | -$19.71 M(-20.0%) | -$101.72 M(-1.2%) |
| Sept 2017 | - | -$24.64 M(+13.4%) | -$103.00 M(-0.1%) |
| June 2017 | - | -$21.73 M(-39.0%) | -$103.11 M(-11.1%) |
| Mar 2017 | - | -$35.64 M(+69.8%) | -$115.98 M(+0.2%) |
| Dec 2016 | -$115.79 M(+11.6%) | -$20.99 M(-15.2%) | -$115.79 M(+6.3%) |
| Sept 2016 | - | -$24.76 M(-28.4%) | -$108.95 M(-3.9%) |
| June 2016 | - | -$34.60 M(-2.4%) | -$113.34 M(+7.9%) |
| Mar 2016 | - | -$35.44 M(+150.4%) | -$105.06 M(+1.2%) |
| Dec 2015 | -$103.76 M(+0.3%) | -$14.15 M(-51.5%) | -$103.76 M(-7.3%) |
| Sept 2015 | - | -$29.15 M(+10.8%) | -$111.99 M(+1.7%) |
| June 2015 | - | -$26.31 M(-23.0%) | -$110.10 M(+4.3%) |
| Mar 2015 | - | -$34.15 M(+52.6%) | -$105.55 M(+2.0%) |
| Dec 2014 | -$103.47 M(+43.9%) | -$22.38 M(-17.9%) | -$103.47 M(+5.2%) |
| Sept 2014 | - | -$27.26 M(+25.3%) | -$98.36 M(+9.9%) |
| June 2014 | - | -$21.75 M(-32.2%) | -$89.54 M(+3.4%) |
| Mar 2014 | - | -$32.07 M(+85.6%) | -$86.60 M(+20.5%) |
| Dec 2013 | -$71.89 M(+43.5%) | -$17.27 M(-6.3%) | -$71.89 M(+5.6%) |
| Sept 2013 | - | -$18.44 M(-2.0%) | -$68.05 M(+12.2%) |
| June 2013 | - | -$18.81 M(+8.4%) | -$60.63 M(+12.6%) |
| Mar 2013 | - | -$17.36 M(+29.2%) | -$53.85 M(+7.5%) |
| Dec 2012 | -$50.09 M(+38.5%) | -$13.44 M(+22.0%) | -$50.09 M(+8.6%) |
| Sept 2012 | - | -$11.02 M(-8.5%) | -$46.13 M(+6.5%) |
| June 2012 | - | -$12.04 M(-11.4%) | -$43.29 M(+6.4%) |
| Mar 2012 | - | -$13.60 M(+43.5%) | -$40.70 M(+12.5%) |
| Dec 2011 | -$36.17 M(+11.4%) | -$9.48 M(+15.8%) | -$36.17 M(+9.1%) |
| Sept 2011 | - | -$8.18 M(-13.4%) | -$33.14 M(-0.3%) |
| June 2011 | - | -$9.45 M(+4.2%) | -$33.24 M(-2.8%) |
| Mar 2011 | - | -$9.07 M(+40.5%) | -$34.21 M(+5.4%) |
| Dec 2010 | -$32.47 M(+6.8%) | -$6.45 M(-22.0%) | -$32.47 M(-12.1%) |
| Sept 2010 | - | -$8.28 M(-20.6%) | -$36.95 M(+7.7%) |
| June 2010 | - | -$10.42 M(+42.3%) | -$34.29 M(+7.1%) |
| Mar 2010 | - | -$7.32 M(-33.0%) | -$32.03 M(+5.4%) |
| Dec 2009 | -$30.40 M(-279.1%) | -$10.93 M(+94.5%) | -$30.40 M(+67.0%) |
| Sept 2009 | - | -$5.62 M(-31.1%) | -$18.20 M(-18.9%) |
| June 2009 | - | -$8.16 M(+43.4%) | -$22.44 M(-243.8%) |
| Mar 2009 | - | -$5.69 M(-549.1%) | $15.60 M(-8.1%) |
| Dec 2008 | $16.98 M(-284.5%) | $1.27 M(-112.9%) | $16.98 M(+37.5%) |
| Sept 2008 | - | -$9.86 M(-133.0%) | $12.35 M(-59.5%) |
| June 2008 | - | $29.89 M(-792.0%) | $30.51 M(-377.5%) |
| Mar 2008 | - | -$4.32 M(+28.5%) | -$10.99 M(+19.5%) |
| Dec 2007 | -$9.20 M | -$3.36 M(-140.5%) | -$9.20 M(-79.7%) |
| Sept 2007 | - | $8.30 M(-171.5%) | -$45.38 M(-24.9%) |
| June 2007 | - | -$11.61 M(+359.4%) | -$60.42 M(+9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$2.53 M(-93.6%) | -$55.05 M(+241.5%) |
| Dec 2006 | -$16.12 M(+167.9%) | -$39.54 M(+486.6%) | -$16.12 M(-160.0%) |
| Sept 2006 | - | -$6.74 M(+8.1%) | $26.85 M(-6.8%) |
| June 2006 | - | -$6.24 M(-117.1%) | $28.80 M(-17.2%) |
| Mar 2006 | - | $36.40 M(+962.8%) | $34.79 M(-678.2%) |
| Dec 2005 | -$6.02 M(-41.9%) | $3.43 M(-171.5%) | -$6.02 M(-47.3%) |
| Sept 2005 | - | -$4.79 M(+1859.2%) | -$11.42 M(+5.8%) |
| June 2005 | - | -$244.60 K(-94.4%) | -$10.80 M(-12.6%) |
| Mar 2005 | - | -$4.40 M(+122.7%) | -$12.35 M(+19.4%) |
| Dec 2004 | -$10.35 M(-11.9%) | -$1.98 M(-52.6%) | -$10.35 M(-9.9%) |
| Sept 2004 | - | -$4.17 M(+131.4%) | -$11.49 M(+14.3%) |
| June 2004 | - | -$1.80 M(-25.0%) | -$10.05 M(-8.3%) |
| Mar 2004 | - | -$2.40 M(-23.0%) | -$10.96 M(-6.6%) |
| Dec 2003 | -$11.74 M(-31.9%) | -$3.12 M(+14.1%) | -$11.74 M(+20.7%) |
| Sept 2003 | - | -$2.73 M(+0.6%) | -$9.73 M(-20.3%) |
| June 2003 | - | -$2.71 M(-14.6%) | -$12.21 M(-17.6%) |
| Mar 2003 | - | -$3.18 M(+188.2%) | -$14.81 M(-14.0%) |
| Dec 2002 | -$17.23 M(-19.6%) | -$1.10 M(-78.8%) | -$17.23 M(-20.8%) |
| Sept 2002 | - | -$5.21 M(-2.0%) | -$21.74 M(-4.4%) |
| June 2002 | - | -$5.32 M(-4.9%) | -$22.74 M(+4.8%) |
| Mar 2002 | - | -$5.59 M(-0.4%) | -$21.69 M(+1.2%) |
| Dec 2001 | -$21.43 M(+365.0%) | -$5.61 M(-9.6%) | -$21.43 M(+32.7%) |
| Sept 2001 | - | -$6.21 M(+45.4%) | -$16.15 M(+29.2%) |
| June 2001 | - | -$4.27 M(-20.0%) | -$12.50 M(+12.6%) |
| Mar 2001 | - | -$5.34 M(+1473.7%) | -$11.10 M(+140.8%) |
| Dec 2000 | -$4.61 M(-50.1%) | -$339.10 K(-86.7%) | -$4.61 M(-17.7%) |
| Sept 2000 | - | -$2.55 M(-11.0%) | -$5.60 M(+2.8%) |
| June 2000 | - | -$2.87 M(-349.2%) | -$5.45 M(+5.2%) |
| Mar 2000 | - | $1.15 M(-186.7%) | -$5.18 M(-43.9%) |
| Dec 1999 | -$9.23 M(+0.3%) | -$1.33 M(-44.7%) | -$9.23 M(+0.3%) |
| Sept 1999 | - | -$2.40 M(-7.7%) | -$9.20 M(-13.2%) |
| June 1999 | - | -$2.60 M(-10.3%) | -$10.60 M(+3.9%) |
| Mar 1999 | - | -$2.90 M(+123.1%) | -$10.20 M(+10.9%) |
| Dec 1998 | -$9.20 M(+17.9%) | -$1.30 M(-65.8%) | -$9.20 M(-8.0%) |
| Sept 1998 | - | -$3.80 M(+72.7%) | -$10.00 M(+22.0%) |
| June 1998 | - | -$2.20 M(+15.8%) | -$8.20 M(+7.9%) |
| Mar 1998 | - | -$1.90 M(-9.5%) | -$7.60 M(-2.6%) |
| Dec 1997 | -$7.80 M(-24.3%) | -$2.10 M(+5.0%) | -$7.80 M(-4.9%) |
| Sept 1997 | - | -$2.00 M(+25.0%) | -$8.20 M(-2.4%) |
| June 1997 | - | -$1.60 M(-23.8%) | -$8.40 M(-3.4%) |
| Mar 1997 | - | -$2.10 M(-16.0%) | -$8.70 M(-15.5%) |
| Dec 1996 | -$10.30 M(+21.2%) | -$2.50 M(+13.6%) | -$10.30 M(+51.5%) |
| Sept 1996 | - | -$2.20 M(+15.8%) | -$6.80 M(-20.9%) |
| June 1996 | - | -$1.90 M(-48.6%) | -$8.60 M(-5.5%) |
| Mar 1996 | - | -$3.70 M(-470.0%) | -$9.10 M(+7.1%) |
| Dec 1995 | -$8.50 M(-14.1%) | $1.00 M(-125.0%) | -$8.50 M(-30.3%) |
| Sept 1995 | - | -$4.00 M(+66.7%) | -$12.20 M(+18.4%) |
| June 1995 | - | -$2.40 M(-22.6%) | -$10.30 M(-4.6%) |
| Mar 1995 | - | -$3.10 M(+14.8%) | -$10.80 M(+9.1%) |
| Dec 1994 | -$9.90 M(+65.0%) | -$2.70 M(+28.6%) | -$9.90 M(+20.7%) |
| Sept 1994 | - | -$2.10 M(-27.6%) | -$8.20 M(+9.3%) |
| June 1994 | - | -$2.90 M(+31.8%) | -$7.50 M(+17.2%) |
| Mar 1994 | - | -$2.20 M(+120.0%) | -$6.40 M(+6.7%) |
| Dec 1993 | -$6.00 M(+36.4%) | -$1.00 M(-28.6%) | -$6.00 M(+20.0%) |
| Sept 1993 | - | -$1.40 M(-22.2%) | -$5.00 M(-3.8%) |
| June 1993 | - | -$1.80 M(0.0%) | -$5.20 M(+8.3%) |
| Mar 1993 | - | -$1.80 M(+12.5%) | -$4.80 M(-5.9%) |
| Dec 1992 | -$4.40 M(-2.2%) | - | - |
| Oct 1992 | - | -$1.60 M(+14.3%) | -$5.10 M(0.0%) |
| July 1992 | - | -$1.40 M(-6.7%) | -$5.10 M(+13.3%) |
| Apr 1992 | - | -$1.50 M(+150.0%) | -$4.50 M(+40.6%) |
| Apr 1992 | -$4.50 M(+32.4%) | - | - |
| Jan 1992 | - | -$600.00 K(-62.5%) | -$3.20 M(-15.8%) |
| Oct 1991 | - | -$1.60 M(+100.0%) | -$3.80 M(0.0%) |
| July 1991 | - | -$800.00 K(+300.0%) | -$3.80 M(+11.8%) |
| Apr 1991 | -$3.40 M(+142.9%) | -$200.00 K(-83.3%) | -$3.40 M(+6.3%) |
| Jan 1991 | - | -$1.20 M(-25.0%) | -$3.20 M(+60.0%) |
| Oct 1990 | - | -$1.60 M(+300.0%) | -$2.00 M(+400.0%) |
| July 1990 | - | -$400.00 K | -$400.00 K |
| Apr 1990 | -$1.40 M | - | - |
FAQ
- What is Celldex Therapeutics annual free cash flow?
- What is the all time high annual FCF for Celldex Therapeutics?
- What is Celldex Therapeutics annual FCF year-on-year change?
- What is Celldex Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly FCF year-on-year change?
- What is Celldex Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Celldex Therapeutics?
- What is Celldex Therapeutics TTM FCF year-on-year change?
What is Celldex Therapeutics annual free cash flow?
The current annual FCF of CLDX is -$109.11 M
What is the all time high annual FCF for Celldex Therapeutics?
Celldex Therapeutics all-time high annual free cash flow is $16.98 M
What is Celldex Therapeutics annual FCF year-on-year change?
Over the past year, CLDX annual free cash flow has changed by -$3.55 M (-3.36%)
What is Celldex Therapeutics quarterly free cash flow?
The current quarterly FCF of CLDX is -$55.88 M
What is the all time high quarterly FCF for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly free cash flow is $36.40 M
What is Celldex Therapeutics quarterly FCF year-on-year change?
Over the past year, CLDX quarterly free cash flow has changed by -$36.73 M (-191.81%)
What is Celldex Therapeutics TTM free cash flow?
The current TTM FCF of CLDX is -$159.66 M
What is the all time high TTM FCF for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM free cash flow is $34.79 M
What is Celldex Therapeutics TTM FCF year-on-year change?
Over the past year, CLDX TTM free cash flow has changed by -$61.76 M (-63.08%)